Literature DB >> 18095188

Validation and quality control of protein microarray-based analytical methods.

Larry J Kricka1, Stephen R Master.   

Abstract

Protein microarray technology is used mainly in the research laboratory and it is being used to uncover important diagnostic and prognostic markers that may one day emerge as routine clinical laboratory tests. It is important that these methods are subject to control procedures, in order to ensure that data of the highest quality are obtained. If quality is not controlled, the assay may yield erroneous results that would mask or confound meaningful diagnostic or prognostic associations. This chapter surveys the range of strategies designed to assure the analytical quality of protein microarray methods and it also highlights some of the potential pitfalls when moving these arrays into routine clinical practice. With the development of appropriate quality control and assurance measures, we anticipate protein microarray-based assays will be of substantial benefit in the future practice of laboratory medicine.

Mesh:

Year:  2007        PMID: 18095188     DOI: 10.1007/s12033-007-0066-5

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  106 in total

1.  UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions.

Authors:  H Ge
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Microarray technology and applications: an all-language literature survey including books and patents.

Authors:  L J Kricka; P Fortina
Journal:  Clin Chem       Date:  2001-08       Impact factor: 8.327

3.  High-throughput genomic and proteomic analysis using microarray technology.

Authors:  J X Huang; D Mehrens; R Wiese; S Lee; S W Tam; S Daniel; J Gilmore; M Shi; D Lashkari
Journal:  Clin Chem       Date:  2001-10       Impact factor: 8.327

Review 4.  Protein microarrays and proteomics.

Authors:  Gavin MacBeath
Journal:  Nat Genet       Date:  2002-12       Impact factor: 38.330

Review 5.  Protein microarrays: meeting analytical challenges for clinical applications.

Authors:  Lance A Liotta; Virginia Espina; Arpita I Mehta; Valerie Calvert; Kevin Rosenblatt; David Geho; Peter J Munson; Lynn Young; Julia Wulfkuhle; Emanuel F Petricoin
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

6.  A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.

Authors:  George Wright; Bruce Tan; Andreas Rosenwald; Elaine H Hurt; Adrian Wiestner; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-04       Impact factor: 11.205

7.  Ligand assays: from electrophoresis to miniaturized microarrays.

Authors:  R P Ekins
Journal:  Clin Chem       Date:  1998-09       Impact factor: 8.327

8.  Simultaneous determination of total IgE and allergen-specific IgE in serum by the MAST chemiluminescent assay system.

Authors:  C R Brown; K W Higgins; K Frazer; L K Schoelz; J W Dyminski; V A Marinkovich; S P Miller; J F Burd
Journal:  Clin Chem       Date:  1985-09       Impact factor: 8.327

9.  Streptavidin-polyvinylamine conjugates labeled with a europium chelate: applications in immunoassay, immunohistochemistry, and microarrays.

Authors:  A Scorilas; A Bjartell; H Lilja; C Moller; E P Diamandis
Journal:  Clin Chem       Date:  2000-09       Impact factor: 8.327

10.  A method for evaluation of the quality of DNA microarray spots.

Authors:  Zhang Boa; Wen-Li Ma; Zi-You Hu; Shi Rong; Yan-Bin Shi; Wen-Ling Zheng
Journal:  J Biochem Mol Biol       Date:  2002-09-30
View more
  9 in total

1.  Accuracy and reproducibility of a multiplex immunoassay platform: a validation study.

Authors:  Julie A Bastarache; Tatsuki Koyama; Nancy E Wickersham; Daphne B Mitchell; Ray L Mernaugh; Lorraine B Ware
Journal:  J Immunol Methods       Date:  2011-01-26       Impact factor: 2.303

Review 2.  Antibody-based protein multiplex platforms: technical and operational challenges.

Authors:  Allison A Ellington; Iftikhar J Kullo; Kent R Bailey; George G Klee
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

3.  Improved reproducibility of reverse-phase protein microarrays using array microenvironment normalization.

Authors:  Troy Anderson; Julia Wulfkuhle; Lance Liotta; Raimond L Winslow; Emanuel Petricoin
Journal:  Proteomics       Date:  2009-12       Impact factor: 3.984

4.  Antibody profiling with protein antigen microarrays in early stage cancer.

Authors:  Brian C-S Liu; Daniel A Dijohnson; Dennis J O'Rourke
Journal:  Expert Opin Med Diagn       Date:  2012-03-22

Review 5.  Glycoprotein analysis using protein microarrays and mass spectrometry.

Authors:  Tasneem Patwa; Chen Li; Diane M Simeone; David M Lubman
Journal:  Mass Spectrom Rev       Date:  2010 Sep-Oct       Impact factor: 10.946

6.  Effects of sample delivery on analyte capture in porous bead sensors.

Authors:  Jie Chou; Luanyi E Li; Eliona Kulla; Nicolaos Christodoulides; Pierre N Floriano; John T McDevitt
Journal:  Lab Chip       Date:  2012-12-21       Impact factor: 6.799

Review 7.  Protein microarrays for personalized medicine.

Authors:  Xiaobo Yu; Nicole Schneiderhan-Marra; Thomas O Joos
Journal:  Clin Chem       Date:  2010-01-14       Impact factor: 8.327

Review 8.  Review of the Use of Liquid Chromatography-Tandem Mass Spectrometry in Clinical Laboratories: Part II-Operations.

Authors:  Brian A Rappold
Journal:  Ann Lab Med       Date:  2022-09-01       Impact factor: 4.941

9.  Quality control, analysis and secure sharing of Luminex® immunoassay data using the open source LabKey Server platform.

Authors:  Josh Eckels; Cory Nathe; Elizabeth K Nelson; Sara G Shoemaker; Elizabeth Van Nostrand; Nicole L Yates; Vicki C Ashley; Linda J Harris; Mark Bollenbeck; Youyi Fong; Georgia D Tomaras; Britt Piehler
Journal:  BMC Bioinformatics       Date:  2013-04-30       Impact factor: 3.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.